Are patients with cancer at higher risk of COVID-19-related death? A systematic review and critical appraisal of the early evidence.

ABSTRACT:

Background

Early reports suggested that COVID-19 patients with cancer were at higher risk of COVID-19-related death. We conducted a systematic review with risk of bias assessment and synthesis of the early evidence on the risk of COVID-19-related death for COVID-19 patients with and without cancer.

Methods and findings

We searched Medline/Embase/BioRxiv/MedRxiv/SSRN databases to 1 July 2020. We included cohort or case-control studies published in English that reported on the risk of dying after developing COVID-19 for people with a pre-existing diagnosis of any cancer, lung cancer, or haematological cancers. We assessed risk of bias using tools adapted from the Newcastle-Ottawa Scale. We used the generic inverse-variance random-effects method for meta-analysis. Pooled odds r

SUBMITTER: Freeman V 

PROVIDER: S-EPMC9169424 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature